Clinical trial
A Community Intervention Effectiveness Study: Single Dose or Two Doses of Bivalent HPV Vaccine (CERVARIX) in Female School Students in Thailand
NCT03747770 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Community Intervention Effectiveness Study: Single Dose or Two Doses of Bivalent HPV Vaccine (CERVARIX) in Female School Students in Thailand
- Lead sponsor
- International Vaccine Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 17, 2018
- Completion date
- June 30, 2023
- Enrollment
- 18,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy